Cancer is a crafty foe, not least because traces often remain after surgery and can trigger a relapse later on. Now a new technology to fight those dangerous leftovers – a cold atmospheric plasma system – has been approved for human clinical trials by the US Food and Drug Administration (FDA).
Continue Reading
The FDA is again warning the public to avoid consuming a product called Miracle Mineral Solution (MMS). Despite over a decade of health warnings and cases of death, the sham product, which is essentially bleach, is still being consumed as a miracle cure for everything from autism to cancer and HIV.
Continue Reading
A newly published statement from the US Food & Drug Administration (FDA) has revealed inaccurate, intentionally manipulated data was included as part of a submission for a major new gene therapy that was approved for public use in May.
Continue Reading
The Wisconsin Department of Health Services is reporting a number of hospitalizations of teenagers displaying severe lung disease, with suspicions of links to e-cigarette use. The FDA has also recently revealed it has accumulated 127 reports of seizures claimed to be related to e-cigarette use.
Continue Reading
Impossible Foods’ plant-based meat alternative will finally be hitting grocery stores in the United States. The FDA has approved its key additive allowing Impossible Foods to move from only selling its products in restaurants and into supermarkets across the country.
Continue Reading
The FDA is cracking down on a number of companies selling cannabidiol (CBD) products accompanied by unsubstantiated health claims. The latest target is a company called Curaleaf, which sells CBD products claimed to treat everything from cancer and Alzheimer’s, to anxiety and inflammation in dogs.
Continue Reading
A novel experimental drug is showing promising results from its final phase of human clinical trials. Part of a new class of drugs called JAK-inhibitors, this therapy targets rheumatoid arthritis sufferers and is hoped to be approved for use by the FDA within the next 12 months.
Continue Reading
The FDA has granted accelerated approval to a new cancer drug called selinexor. This pill has been found to be successful in treating multiple myeloma in patients that hadn’t had success with other treatments. But at this very early stage the drug comes with some major caveats.
Continue Reading
A new safety alert, issued by the Food and Drug Administration (FDA), is recommending extra precautions for those medical and scientific professionals using fecal microbiota transplants (FMT) after revealing one person recently died due to a bacterial infection.
Continue Reading
A new gene therapy to treat pediatric patients with spinal muscular atrophy has been approved by the FDA. The single dose, designed to correct a gene mutation causing the rare disease, has been priced at US$2.1 million by company Novartis, making it the most expensive drug in the world to date.
Continue Reading
See the stories that matter in your inbox every morning